USPTO Patent US12582642B2 for Treating Bovine Papillomatosis

ChangeBridge: Patent Grants - Therapeutics (A61P)

Published March 24th, 2026

Detected March 24th, 2026

Summary

The USPTO has granted patent US12582642B2 to KINOPHARMA, INC. for a composition and method to treat bovine papillomatosis. The patent covers compounds represented by Formula (I) or their pharmaceutically acceptable salts.

View original document View source feed page

What changed

The United States Patent and Trademark Office (USPTO) has issued patent US12582642B2 to KINOPHARMA, INC. This patent covers a composition containing a specific compound (Formula I) or its pharmaceutically acceptable salt, intended for the treatment, amelioration, and/or suppression of bovine papillomatosis caused by bovine papillomavirus. The patent also includes a method for administering this compound to cows.

This is a grant of intellectual property and does not impose new regulatory obligations on entities outside of those involved in the patent holder's operations or potential licensees. Companies in the veterinary pharmaceutical sector may wish to review the patent claims for potential licensing opportunities or to ensure their own research and development activities do not infringe upon this granted patent. No immediate compliance actions are required for most entities.

Source document (simplified)

← USPTO Patent Grants

Composition for treating, improving, and/or preventing progression of bovine papillomatosis caused by bovine papillomavirus

Grant US12582642B2 Kind: B2 Mar 24, 2026

Assignee

KINOPHARMA, INC.

Inventors

Hiroshi Onogi, Tomas Javier Acosta Ayala

Abstract

Provided are a composition for treatment and the like of bovine papillomatosis caused by bovine papillomavirus, and a method using the same. Provided are a composition for treatment, amelioration, and/or suppressing the progression of bovine papillomatosis caused by bovine papillomavirus, the composition containing, as an active ingredient, a compound represented by Formula (I) below or a pharmaceutically acceptable salt of the compound; and a method for treating, ameliorating, and/or suppressing progression of, bovine papillomatosis caused by bovine papillomavirus, the method including administering, to a cow, a compound represented by Formula (I) below or a pharmaceutically acceptable salt of the compound: